Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Illinois Society for the Prevention of Blindness Partners with Horizon Therapeutics to Provide Grants for Low Vision Equipment for Illinois Residents in Need


News provided by

Illinois Society for the Prevention of Blindness

Feb 21, 2023, 09:15 ET

Share this article

Share toX

Share this article

Share toX

The Illinois Society for the Prevention of Blindness, and Horizon Therapeutics are partnering to provide grants for low vision aids to Illinois patients in need.
The Illinois Society for the Prevention of Blindness, and Horizon Therapeutics are partnering to provide grants for low vision aids to Illinois patients in need.
Youtube
Youtube

Nonprofit group, Illinois Society for the Prevention of Blindness (ISPB), is Teaming up with Horizon Therapeutics to Offer Grants for Low Vision Aids to Patients as Part of the ISPB Low Vision Equipment Reimbursement Program

CHICAGO, Feb. 21, 2023 /PRNewswire-PRWeb/ -- As part of February's Low Vision Awareness Month, nonprofit organization Illinois Society for the Prevention of Blindness (ISPB) is partnering with Horizon Therapeutics, a global biotechnology company focused on rare, autoimmune and severe inflammatory diseases, to provide much-needed low vision equipment to the underserved in Illinois as part of the ISPB Low Vision Equipment Reimbursement Program. The program provides reimbursement for low vision aids, scleral lenses, and eyeglasses, to those who cannot otherwise afford them. Horizon is supporting the program with a donation of $50,000.

Low Vision is defined as vision loss that cannot be corrected by medical or surgical treatments, or conventional eyeglasses, according to the American Academy of Ophthalmology. The Centers for Disease Control and Prevention's Vision and Eye Health Surveillance System (VEHSS) estimates that there are more 243,000 Illinois residents experiencing vision loss.

“Unfortunately, low vision equipment, which can be very expensive, is not covered by health insurance, including Medicare and Medicaid,” said Elyse Fineman, executive director at ISPB. “Thanks to the generous support of Horizon, we can now expand our program to provide these tools to those in need.”

Post this

Since its inception, the ISPB Low Vision Equipment Reimbursement Program has provided thousands of patients with no-cost low vision aids and glasses. These tools help children succeed in the classroom, adults to continue to work, and seniors to remain independent.

Since 1916, ISPB has developed relationships with community partners, many of whom treat underserved communities, to identify low-income patients. These partners find the most effective low vision equipment and ensure that it fits the needs of the patient before applying for the ISPB reimbursement program. Current ISPB partners include Lurie Children's Hospital, The Rosenbloom Center at the Illinois Eye Institute, The Center for Sight and Hearing, and The Chicago Lighthouse.

"Unfortunately, low vision equipment, which can be very expensive, is not covered by health insurance, including Medicare and Medicaid," said Elyse Fineman, executive director at ISPB. "Thanks to the generous support of Horizon, we can now expand our program to provide these tools to those in need."

"Through our work with the Thyroid Eye Disease (TED) community, we've seen the important role that accessibility tools and adaptive technology can play for those living with low vision," said Matt Flesch, vice president, communications and patient advocacy, Horizon Therapeutics. "However, those tools and resources can be incredibly cost prohibitive. These grants will help remove some of those financial barriers and help people who are blind or living with low vision access necessary equipment to live more independent lives."

Horizon also recently supported the launch of the newly redesigned Prevent Blindness resource, "Living Well With Low Vision." The site, designed for patients, care partners and professionals, offers a wide variety of resources including patient guides, a low vision news feed, database of Low Vision Resource Directories, and much more.

For more information on the ISPB Low Vision Equipment Reimbursement Program, please visit https://eyehealthillinois.org/financial-support-for-visual-aids/. (Patients should contact partnering clinics directly for an appointment.) To visit the Living Well With Low Vision resource, go to LowVision.PreventBlindness.org.

About The Illinois Society for the Prevention of Blindness (ISPB)
ISPB was founded in 1916 to reduce preventable causes of blindness. ISPB has a rich history of promoting vision and eye health in the state of Illinois and was instrumental in advocating for passage of several sight-saving bills before the Illinois legislature. Dedicated to the care, protection, and preservation of sight, ISPB programs today continue to stress education and safety; access to care for glasses and low vision equipment; and research grant opportunities. We also provide speakers and screening booths at health fairs and other events. The work of the ISPB is supported by the generosity of individuals, businesses, organizations, corporations, and foundations. Contributions, remembrances, wills, bequests, and grants make our important work possible. For more information, visit us at EyeHealthIllinois.org, and follow us on Facebook, Twitter, Instagram, and LinkedIn.

About Prevent Blindness
Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

About Horizon
Horizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit http://www.horizontherapeutics.com and follow us on Twitter, LinkedIn, Instagram and Facebook.
###

Media Contact

Sarah Hecker, Prevent Blidndness, 312.262.6035, [email protected]

Ruby Barraza, Illinois Society for the Prevention of Blindness, (312) 363-6023, [email protected]

Twitter

SOURCE Illinois Society for the Prevention of Blindness

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.